Open Medicine EU

Archives for

The European Medicines Agency is in difficulty, perhaps even in crisis. It is time for DG Sanco to take action. The board has been unable to approve either of the two short-listed candidates for Executive Director and the European Parliament has refused to discharge the agency’s accounts for 2009. The Parliament is one element of… » read more

Posted by Jim Murray

In a previous post , I commented on the fact that the former Executive Director joined a number of industry-based groups immediately after leaving the European Medicines Agency. On 21st March, the EMA board gave its approval to the former director’s activities, and imposed some limits for the next two years, including “prohibitions on taking… » read more

Posted by Jim Murray

Medicines are sometimes withdrawn from the market or heavily restricted in their use, when the risks are judged to outweigh the potential benefits. Is this just a case of bad luck or an unavoidable risk when it happens, or is it something more? According to a fascinating article in the American Journal of Public Health… » read more

Posted by Jim Murray